Fresh from the biotech pipeline 2017: A positive regulatory environment & a raft of drug approvals that included the first US #genetherapy buoyed the sector. 's flexibility & focus on marketplace competition is likely to galvanize innovators in 2018 go.nature.com/2DZE55S
Conversation
On our blog, commissioner @SGottliebFDA talks further with about #drugprices, competition and new therapeutic modalities go.nature.com/2DSRvQa
